Brooklyn Investment Group Takes Position in Roche Holding AG (OTCMKTS:RHHBY)

Brooklyn Investment Group acquired a new stake in shares of Roche Holding AG (OTCMKTS:RHHBY) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 991 shares of the company’s stock, valued at approximately $40,000.

A number of other institutional investors have also recently made changes to their positions in RHHBY. Canopy Partners LLC grew its position in Roche by 4.6% in the third quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock worth $310,000 after acquiring an additional 344 shares in the last quarter. Verity Asset Management Inc. purchased a new position in Roche in the third quarter worth about $253,000. Kornitzer Capital Management Inc. KS grew its position in Roche by 1.3% in the third quarter. Kornitzer Capital Management Inc. KS now owns 136,923 shares of the company’s stock worth $5,490,000 after acquiring an additional 1,798 shares in the last quarter. AlphaMark Advisors LLC purchased a new position in Roche in the third quarter worth about $149,000. Finally, Diversified Trust Co lifted its stake in Roche by 6.4% in the third quarter. Diversified Trust Co now owns 59,742 shares of the company’s stock worth $2,396,000 after purchasing an additional 3,613 shares during the last quarter.

Analyst Upgrades and Downgrades

RHHBY has been the subject of several analyst reports. Bank of America raised shares of Roche from a “neutral” rating to a “buy” rating in a research note on Friday, September 13th. Deutsche Bank Aktiengesellschaft downgraded shares of Roche from a “hold” rating to a “sell” rating in a research note on Friday, September 13th. Three research analysts have rated the stock with a sell rating, one has issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold”.

Roche Stock Up 1.4 %

Roche stock opened at $36.24 on Friday. The company has a 50 day moving average price of $38.24 and a 200-day moving average price of $37.44. Roche Holding AG has a fifty-two week low of $29.20 and a fifty-two week high of $42.43.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.